GROWTH-HORMONE (GH) SECRETION IN ACTIVE ACROMEGALY AFTER THE COMBINED ADMINISTRATION OF GH-RELEASING HORMONE AND GH-RELEASING PEPTIDE-6

被引:26
作者
POPOVIC, V
DAMJANOVIC, S
MICIC, D
PETAKOV, M
DIEGUEZ, C
CASANUEVA, FF
机构
[1] UNIV SANTIAGO DE COMPOSTELA, FAC MED, DEPT PHYSIOL, E-15780 SANTIAGO, SPAIN
[2] UNIV SANTIAGO DE COMPOSTELA, FAC MED, DEPT MED, SANTIAGO, SPAIN
[3] UNIV BELGRADE, CTR CLIN, INST ENDOCRINOL, YU-11000 BELGRADE, YUGOSLAVIA
关键词
D O I
10.1210/jc.79.2.456
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (called GHRP-6) is a synthetic compound that releases GH in a dose-related, specific, and nonspecies-specific manner, through mechanisms different from those of GHRH. Being, normally, more potent than GHRH, GHRP-6 shows a striking synergistic action when administered simultaneously with GHRH, although the mechanisms and point of action of such a potentiating effect are unknown. The aim of the present study was 2-fold: 1) to further characterize the actions and mechanisms of GHRP-6 as well as its synergistic effects, and 2) to study its actions in acromegalic patients. Eleven acromegalic patients and 12 normal subjects, age and sex matched as controls, underwent 3 tests each on separate occasions, being challenged with GHRH (100 mu g, iv), GHRP-6 (90 mu g, iv), or GHRH plus GHRP-6. GH was analyzed as the area under the curve (mean +/- SE; micrograms per L/120 min). In normal subjects, GH secretion was 686 +/- 227 after GHRH, 1787 +/- 510 after GHRP-6, and 4111 +/- 671 after GHRH plus GHRP-6; the level of GH secreted after GHRH plus GHRP-6 treatment was significantly (P < 0.05) higher than the arithmetic sum of GH levels after both compounds administered separately. In acromegalic patients, the level of GH secreted after GHRH was 1468 +/- 499, that after GHRP-6 was 2595 +/- 762, and that after GHRH plus GHRP-6 was 4949 +/- 1043; this last value was not significantly different from the arithmetical addition of levels produced by both compounds administered separately. These results indicate that GH-secreting pituitary adenomas respond surprisingly well to either GHRH or GHRP-6 despite being deprived for long periods (even years) of the physiological regulation exerted by the hypothalamus. In addition, the synergistic action of GHRH plus GHRP-6 was observed in normal subjects, but not in acromegalic patients. These results suggest that GHRP-6 does not need to operate through hypothalamic factors to exert its GH-releasing action, even for eliciting a greater response than GHRH. On the other hand, the synergistic effect of GHRH plus GHRP-6 appears to need the cooperation of the hypothalamus, but how this occurs is still undetermined.
引用
收藏
页码:456 / 460
页数:5
相关论文
共 50 条
[41]   Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitus [J].
Weffort, RFV ;
RamosDias, JC ;
Chipoch, C ;
Lengyel, AMJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (06) :706-710
[42]   Growth hormone (GH)-releasing activity of chicken GH-releasing hormone (GHRH) in chickens [J].
Harvey, S. ;
Gineste, C. ;
Gaylinn, B. D. .
GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2014, 204 :261-266
[43]   GROWTH-HORMONE (GH)-RELEASING EFFECTS OF SYNTHETIC PEPTIDE GH-RELEASING PEPTIDE-2 AND GH-RELEASING HORMONE(1-29NH(2)) IN CHILDREN WITH GH INSUFFICIENCY AND IDIOPATHIC SHORT STATURE [J].
TUILPAKOV, AN ;
BULATOV, AA ;
PETERKOVA, VA ;
ELIZAROVA, GP ;
VOLEVODZ, NN ;
BOWERS, CY .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (09) :1199-1204
[44]   INHIBITION BY PREDNISONE OF GROWTH-HORMONE (GH) RESPONSE TO GH-RELEASING HORMONE IN NORMAL MEN [J].
KAUFMANN, S ;
JONES, KL ;
WEHRENBERG, WB ;
CULLER, FL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (06) :1258-1261
[45]   OPIOIDS STIMULATE GROWTH-HORMONE (GH) RELEASE IN MAN INDEPENDENTLY OF GH-RELEASING HORMONE [J].
DELITALA, G ;
TOMASI, PA ;
PALERMO, M ;
ROSS, RJM ;
GROSSMAN, A ;
BESSER, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (02) :356-358
[46]   BLUNTED GROWTH-HORMONE (GH) RESPONSES TO GH-RELEASING HORMONE IN MAJOR DEPRESSIVE DISORDER [J].
LESCH, KP ;
LAUX, G ;
PFULLER, H ;
BECKMANN, H .
NEUROENDOCRINOLOGY LETTERS, 1987, 9 (03) :224-254
[47]   THE INFLUENCE OF DEXAMETHASONE ON GROWTH-HORMONE (GH) - RESPONSE TO GH-RELEASING HORMONE IN NORMAL MEN [J].
RUPPRECHT, R ;
NIEHAUS, A ;
LESCH, KP .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1990, 79 (1-2) :51-57
[48]   INHIBITION OF THE GROWTH-HORMONE (GH) RESPONSE TO GH-RELEASING HORMONE BY CONSTANT MET-GH INFUSIONS [J].
PONTIROLI, AE ;
LANZI, R ;
POZZA, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (05) :956-959
[49]   Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness [J].
VandenBerghe, G ;
deZegher, F ;
Bowers, CY ;
Wouters, P ;
Muller, P ;
Soetens, F ;
Vlasselaers, D ;
Schetz, M ;
Verwaest, C ;
Lauwers, P ;
Bouillon, R .
CLINICAL ENDOCRINOLOGY, 1996, 45 (03) :341-351
[50]   Secretory mechanisms of growth hormone (GH)-releasing peptide-, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly [J].
Hanew, K ;
Utsumi, A ;
Tanaka, A ;
Ikeda, H ;
Yokogoshi, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10) :3578-3583